Creative Biolabs-Immuno-oncology

Anti-SELL (clone HuDREG-2E0Z0Z) SynExpress la-Cy3-I17-X Modified CD8+ T cells (CAT#: ITS-1224-CR18)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target SELL (clone HuDREG-2E0Z0Z). We employs the pUC (lac-Cy3-IL-17-XbaI) vector components and the SynExpress system of the Introns Knockout/Negative feedback for a robust and sustained response against cancers.
Host
humanized
Target
SELL
Clone
HuDREG-2E0Z0Z
Species Reactivity
Human; Cynomolgus; Monkey; Chimpanzee; Baboon
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
lac
Effector Gene
IL-17
Insertion Sites
XbaI
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
pUC
Transformation Accuracy
0.89
Cell Culture
Plate Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.